Related references
Note: Only part of the references are listed.Duration of Chemotherapy for Metastatic Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Alessandra Gennari et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Quality-of-Life Measurement in Randomized Clinical Trials in Breast Cancer: An Updated Systematic Review (2001-2009)
Julie Lemieux et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Maintenance treatment with Pegylated liposomal doxorubicin versus observation following induction chemotherapy for metastatic breast cancer: GEICAM 2001-01 study
Emilio Alba et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer
C. K. Lee et al.
BRITISH JOURNAL OF CANCER (2010)
Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials
Chantal Quinten et al.
LANCET ONCOLOGY (2009)
Lack of benefit of maintenance paclitaxel in first-line chemotherapy in metastatic breast cancer
Alessandra Gennari et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer
F Efficace et al.
EUROPEAN JOURNAL OF CANCER (2004)
Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: Cancer and Leukemia Group B Trial 9342
EP Winer et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients: clinical outcomes and oncologists' preferences
MA Nooij et al.
EUROPEAN JOURNAL OF CANCER (2003)
Health-related quality-of-life measurement in randomized clinical trials in breast cancer - Taking stock
PJ Goodwin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer
JA Kramer et al.
EUROPEAN JOURNAL OF CANCER (2000)
Share Paper
